...
首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
【24h】

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

机译:玻璃体腔注射曲安奈德与贝伐单抗联合治疗与年龄相关的黄斑变性中大型视网膜色素上皮脱离相关的脉络膜新生血管。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To discuss the effect and outcome of a combined intravitreal triamcinolone acetonide (IVTA) injection with intravitreal bevacizumab (IVB) in treating choroidal neovascularization (CNV) associated with large retinal pigment epithelial detachment (PED) in age-related macular degeneration (AMD). DESIGN: Prospective, consecutive, observational case series. METHODS: Seven eyes (five patients) with CNV associated with large PED in AMD were treated by IVTA (4 mg/ 0.1 ml), followed by a IVB (1.25 mg/0.05 ml) 1 week later. Patients were evaluated for best-corrected visual acuity (BCVA) and optical coherence tomography (OCT) at baseline, at 1 week and every 6 weeks. Fluorescein angiography (FA) and indocyanine green angiography (ICG) were performed at baseline and every 3 months afterwards. Indications for retreatment by combined injection were defined as persistent PED with subretinal and/or intraretinal fluid on OCT. Patients with flattening of the PED and activity leakage demonstrated by OCT underwent subsequent IVB. RESULTS: The mean duration of follow-up was 11 months (range 9-14 months). BCVA at baseline averaged 20/125, and 20/80 at the end of follow-up. FA showed no leakage from the lesion in four eyes at the end of follow-up, and three eyes showed a decrease in leakage. Average central foveal thickness was (CFT) 325.7 microns at baseline and 209.2 microns at the end. The average size of the PED was 2.34 disk diameters (range 1.33-3.25) at baseline, and the PED disappeared in four eyes, while it decreased in size at the end in the remaining three. The subretinal fluid disappeared in all patients at the end. The combined treatment (IVTA with IVB 1 week later) was repeated in four eyes, and the number of IVB after combined injection ranged from one to three. No RPE tear appeared during follow-up. Two eyes developed glaucoma controlled by topical medication. There were no other ocular or systemic complications CONCLUSION: Combined IVB and IVTA therapy seems to be an effective and safe procedure to treat CNV associated with large PED in AMD.
机译:目的:探讨玻璃体内注射曲安奈德(IVTA)与玻璃体内贝伐单抗(IVB)联合注射治疗与年龄相关性黄斑变性(AMD)相关的脉络膜新生血管(CNV)与大视网膜色素上皮脱离(PED)的关系和效果。 。设计:前瞻性,连续性,观察性病例系列。方法:7周(5名患者)CNV与大PED相关的AMD患者接受IVTA(4 mg / 0.1 ml)治疗,随后1周后接受IVB(1.25 mg / 0.05 ml)治疗。在基线,第1周和每6周对患者进行最佳矫正视敏度(BCVA)和光学相干断层扫描(OCT)评估。在基线时以及之后每3个月进行一次荧光素血管造影(FA)和吲哚菁绿血管造影(ICG)。通过联合注射进行再治疗的适应症定义为OCT上存在视网膜下和/或视网膜内液的持续性PED。 OCT证实PED扁平化和活动性漏出的患者随后接受了IVB。结果:平均随访时间为11个月(范围9-14个月)。基线时的BCVA平均为20/125,随访结束时为20/80。随访结束时,四只眼中FA未显示出病灶渗漏,三只眼显示出渗漏减少。中心凹平均厚度在基线处为(CFT)325.7微米,在末期为209.2微米。 PED的平均大小在基线处为2.34盘直径(范围1.33-3.25),四只眼中PED消失,而其余三只眼中PED的大小减小。最后,所有患者的视网膜下液均消失。在四只眼中重复组合治疗(IVTA与IVB 1周后),并且联合注射后的IVB数量为一到三。随访期间未见RPE撕裂。两只眼睛出现局部用药控制的青光眼。结论:IVB和IVTA联合治疗似乎是治疗AMD中大PED相关性CNV的有效且安全的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号